Use of a liquid allergy vaccine formulation for oromucosal administration

The present invention relates to the use of an allergen for the manufacture of a liquid vaccine formulation for preventing or treating allergy in a subject by oromucosal administration in a dosage regimen comprising no up-dosing.

Saved in:
Bibliographic Details
Main Authors DOMINGO BARBER HERNANDEZ, FERNANDO DE LA TORRE MARTINEZ, PILAR RICO NIETO
Format Patent
LanguageEnglish
Published 10.05.2007
Subjects
Online AccessGet full text

Cover

Loading…